Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
16.09. | GAIASO Appoints Tracey Brown Chief Executive Officer | ||
16.09. | Takeda to Transport Products Between Europe and the U.S. with Sailing Cargo Vessels | ||
15.09. | Monte Rosa & Novartis Partner to Develop Immune-Mediated Disease Treatments | ||
15.09. | FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium | ||
15.09. | Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin | ||
15.09. | Chrysalis Taps Adam Bartley as Chief Operating Officer | ||
15.09. | Labcorp Completes Acquisition of BioReference Health Assets | ||
15.09. | Lonza Appoints Jason Berndt as Head of Group Operations | ||
15.09. | Corstasis Therapeutics' Enbumyst Gains FDA Approval | ||
15.09. | Abzena Introduces New GS Knockout Platforms | ||
15.09. | Avid Bioservices Appoints Kenneth Bilenberg as CEO | ||
12.09. | Alkermes Names Joshua Reed Chief Financial Officer | ||
12.09. | Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial | ||
12.09. | Medincell Appoints Three New Members to Board of Directors | ||
11.09. | Bausch Health Companies Acquires Durect Corporation | ||
11.09. | CPHI Frankfurt Returns to Germany October 28-30 | ||
11.09. | Charles River Collaborates to Advance Novel Oncology Research & Development | ||
11.09. | Corstasis Therapeutics Appoints Amin Medjamia as VP of Medical Affairs | ||
11.09. | Takeda Appoints Rhonda Pacheco as President of U.S. Business Unit | ||
11.09. | Matica Bio, Cirsium Biosciences Enter AAV Manufacturing Pact | ||
10.09. | AGC Biologics Seattle Facility Achieves Regulatory and Operational Milestones | ||
10.09. | Novo Nordisk Restructures, Reduces Workforce by 11% | ||
10.09. | BioIVT Announces New Office and Lab in Woodbury, NY | ||
10.09. | Wheeler Bio, Pharmefex Consulting Enter Partnership | ||
10.09. | Symeres Acquires DGr Pharma |